An archived copy of the webcast will be available for up to one year on the "Investors” section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events.

Neurocrine Biosciences, Inc. today announced the release of findings from a new survey conducted by The Harris Poll highlighting the profound negative impact of tardive dyskinesia on patients and ...